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Abstract
Background: To analyze the potential effect of social
inequality on pancreatic cancer risk in Western Europe, by
reassessing the association within the European Prospective
Investigation into Cancer and Nutrition (EPIC) Study, includ-
ing a larger number of cases and an extended follow-up.
Methods: Data on highest education attainedwere gathered
for 459,170 participants (70% women) from 10 European
countries. A relative index of inequality (RII) based on adult
education was calculated for comparability across countries
and generations. Cox regression models were applied to esti-
mate relative inequality in pancreatic cancer risk, stratifying by
age, gender, and center, and adjusting for known pancreatic
cancer risk factors.
Results: A total of 1,223 incident pancreatic cancer cases
were included after a mean follow-up of 13.9 (4.0) years.
An inverse social trend was found in models adjusted for
age, sex, and center for both sexes [HR of RII, 1.27; 95%
confidence interval (CI), 1.02–1.59], which was also signif-
icant among women (HR, 1.42; 95% CI, 1.05–1.92). Further
adjusting by smoking intensity, alcohol consumption,
body mass index, prevalent diabetes, and physical activity
led to an attenuation of the RII risk and loss of statistical
significance.
Conclusions: The present reanalysis does not sustain the
existence of an independent social inequality influence on
pancreatic cancer risk in Western European women and men,
using an index based on adult education, the most relevant
social indicator linked to individual lifestyles, in a context of
very low pancreatic cancer survival from (quasi) universal
public health systems.
Impact: The results do not support an association between
education and risk of pancreatic cancer.
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Introduction
The incidence and mortality of pancreatic cancer have under-
gone a parallel rise in Europe and North America in the last
decades (1). Meanwhile, pancreatic cancer 5-year survival is
among the lowest of the common cancers (7%), and treatment
advances have been minimal, despite the high-quality and near-
universal coverage of health systems in Western Europe.
It is established that most pancreatic cancer are noninherited,
although family history also conveys a higher disease risk (2).
Nevertheless, little is knownon the etiopathogenesis of pancreatic
cancer, and effective screening tests are lacking.
Previous literature suggests a causal role for body fatness and,
probably, adult height, where an evidence for alcohol, red or
processed meat, and other dietary factors is limited or incon-
clusive (2). The established pancreatic cancer risk factors are
tobacco smoking, body mass index (BMI), diabetes, and chron-
ic pancreatitis (3).
Social determinants are linked to lifestyle cancer risk factors.
However, a preceding study on the association of pancreatic
cancer with socioeconomic status within the European Prospec-
tive Investigation into Cancer and Nutrition (EPIC) was incon-
clusive (4). This is the reason why we reanalyze this association
including a larger number of cases and a longer follow-up using
updated end-point data from the EPIC cohorts.
Materials and Methods
Details on study methods and sample characteristics can be
found elsewhere (4, 5). EPIC recruited volunteers from 10
European countries between 1992 and 2000, who were 35 to
70 years old at baseline. A relative index of inequality (RII) was
estimated on the basis of an educational ranking of individuals
within each sex, age groups, and center (4). Of the 491,992
participants without prevalent cancer, those without baseline
lifestyle or dietary information (n ¼ 6,259), extreme energy
reporters (n ¼ 9,573), and individuals with missing data on
education (n ¼ 16,931, including 19 pancreatic cancer cases)
were excluded. Furthermore, participants who developed a
different primary cancer prior to a pancreatic and neuroendo-
crine cancer (n ¼ 54) or nonmalignant tumors (n ¼ 5) were
censored at the date of the event, leaving a final sample of
457,947 noncases and 1,223 pancreatic cancer cases, with a
mean follow-up of 13.9 ( 4.0) years and 6,401,413 person-
years (Supplementary Table S1).
The RII was estimated through Cox regression with age as
the time variable. Effect modification was evaluated by sex,
age, BMI, smoking, alcohol, diabetes, and European region.
Interactions were assessed using likelihood ratio tests. Sensi-
tivity analyses were conducted to test the robustness of results
against potential biases due to reverse causation or residual
confounding.
Analyseswere conducted using R version 3.3.2, and two-sided P
values <0.05 were considered statistically significant.
Results
Table 1 shows baseline participants' characteristics by the
educational ranks of RII. An inverse and statistically significant
social trend was found in models adjusted for age, sex, and
center for both sexes combined [HR of RII, 1.27; 95% confi-
dence interval (CI), 1.02–1.59], which was stronger among
women (HR, 1.42; 95% CI, 1.05–1.92; Table 2). Multivariate
adjustment attenuated RII estimates causing the loss of statis-
tical significance. Results were similar when considering edu-
cation as the exposure.
There was no effect modification in stratified analysis (Supple-
mentary table S2). Sensitivity analyses adding new variables or
excluding participants caused minor attenuations, which
remained not significant (Supplementary table S2). Country-wise
exclusion of participants resulted in a significant RII when exclud-
ing the Netherlands (RII, 1.29; 95% CI, 1.02–1.63; Supplemen-
tary table S3).
Discussion
Education is the most common individual measure of social
position because it allows classifying all individuals from young
adulthood. Our results do not endorse a social stratification of
pancreatic cancer risk in Western Europe, after accounting for
major potential confounders.
We cannot discard plausible generation effects and misclassi-
fication due to the differences across educational systems. Fur-
thermore, the assumption that all educational categories are
hierarchically ordered is not always straightforward, as for voca-
tional and secondary education. However, the alternative use of
education as the exposure and the sensitivity analyses conducted
exhibited similar associations, supporting the robustness of
results. Grouping secondary and vocational education did not
result in higher pancreatic cancer risk (Table 2), and the compar-
isonof extreme levels (university versus primary or lower)was not
significant either.
Our results are in agreementwith an earlier study evaluating the
occupational status of United Kingdom's government employees,
which did not obtain a significant risk of pancreatic cancer among
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the least affluent (6).On the contrary, a cohort study performed in
Norway found higher risk of pancreatic cancer in farmers versus
low occupational groups, which did not change after lifestyle
adjustments (7).
Among the limitations, we had no data on developmental
factors affecting linear growth (2). Nevertheless, a previous
case–control study evaluating serum insulin-like growth factor
I (IGF-I) and IGFBP-3 concentrations was unable to support a role
for the IGF signaling axis on pancreatic cancer risk (8). Finally, we
did not have information on family history (pancreatic cancer is
more frequent among family members). However, it is estab-
lished that over 90% of incident pancreatic cancers are sporadic
(mainly attributable to genetic mutations or epigenetic dysregu-
lation), and not inherited.
Conclusions
These results do not support an association between education
and risk of pancreatic cancer.
Table 2. Association between education and the RII with pancreatic cancer in the EPIC Cohorts Study
Model 1 Model 2
Person-years Cases HR (95% CI) HR (95% CI)
All University 1,570,473 233 1 (ref.) 1 (ref.)
Secondary or vocational 2,842,462 479 1.08 (0.92–1.28) 1.05 (0.89–1.23)
Primary or less 1,988,478 511 1.20 (1.01–1.42) 1.12 (0.94–1.33)
Plinear trend 0.036 0.201
RII 6,401,413 1,223 1.27 (1.02–1.59) 1.17 (0.93–1.46)
Plinear trend 0.030 0.173
Pnonlinear trend 0.113 0.464
Women University 1,050,615 104 1 (ref.) 1 (ref.)
Secondary or vocational 2,091,455 291 1.06 (0.84–1.35) 1.05 (0.83–1.34)
Primary or less 1,332,521 290 1.27 (0.98–1.64) 1.18 (0.91–1.54)
Plinear trend 0.046 0.164
RII 4,474,592 685 1.42 (1.05–1.92) 1.29 (0.95–1.75)
Plinear trend 0.022 0.103
Pnonlinear trend 0.113 0.331
Men University 519,858 129 1 (ref.) 1 (ref.)
Secondary or vocational 751,007 188 1.12 (0.89–1.41) 1.04 (0.83–1.31)
Primary or less 655,957 221 1.13 (0.89–1.44) 1.03 (0.81–1.31)
Plinear trend 0.330 0.735
RII 1,926,821 538 1.12 (0.81–1.54) 1.00 (0.72–1.38)
Plinear trend 0.488 0.981
Pnonlinear trend 0.729 0.923
Psex interaction 0.310 0.249
NOTE: Model 1, adjusted by sex and stratified by center and baseline age categories; model 2, as model 1, plus further adjustment by smoking intensity, alcohol
consumption,BMI, prevalent diabetes, andphysical activity. TheRII expresses the ratio of the expectedpancreatic cancer risk between themost educated (reference)
and the least educated participants in the cohorts.
Table 1. Baseline participants' characteristics in the EPIC Study by the RII
RIIa
(0–0.25) (0.25–0.50) (0.50–0.75) (0.75–1.00)
N 112,542 99,384 149,168 98,135
Person-years/cases 1,544,380/270 1,447,272/260 2,031,255/337 1,378,506/356
Women 79,201 (70.4) 66,520 (66.9) 110,843 (74.3) 64,274 (65.5)
Age (years) 51.2 (8.5) 48.7 (11.1) 51.6 (9.7) 52.5 (9.5)
BMI (kg/m2) 24.6 (3.8) 24.9 (4.0) 26.0 (4.6) 26.1 (4.3)
Normal weight 67,718 (60.2) 56,077 (56.4) 69,011 (46.3) 43,954 (44.8)
Overweight 35,450 (31.5) 33,326 (33.5) 53,340 (35.8) 38,389 (39.1)
Obese 9,374 (8.3) 9,981 (10.0) 26,817 (18.0) 15,792 (16.1)
Smoking
Never 54,101 (48.1) 47,451 (47.7) 80,811 (54.2) 42,639 (43.4)
Former 33,065 (29.4) 27,929 (28.1) 33,824 (22.7) 26,885 (27.4)
Current 22,858 (20.3) 23,105 (23.2) 31,396 (21.0) 27,215 (27.7)
Physically inactive 19,420 (17.3) 16,633 (16.7) 38,757 (26.0) 19,998 (20.4)
Diabetes 2,145 (2.0) 1,645 (1.8) 5,492 (3.9) 2,842 (3.1)
Energy intake (kcal/day) 2,109 (596) 2,054 (606) 2,075 (629) 2,070 (649)
Fruit and vegetable intake (g/day) 455.1 (274.6) 409.5 (251.7) 484.6 (278.9) 390.6 (254.3)
Red and processed meat intake (g/day) 75.8 (48.2) 68.5 (49.7) 76.6 (50.9) 80.3 (54.5)
Alcohol consumers 101,183 (89.9) 91,415 (92.0) 118,897 (79.7) 85,003 (86.6)
Alcohol consumption (g/day)b 14.98542 (17.548) 12.80948 (15.672) 13.88367 (18.631) 12.46815 (17.928)
NOTE: Values are mean and SD or numbers and percentages.
aEducational rank from most educated (0) to least educated (1), corresponding to the mean proportion of the population with a higher education within the
corresponding group of sex, age category, and center.
bMean intake estimated among alcohol consumers only.
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